Device Trial Radar · NCT00953173
HERO Study: Helping Evaluate Reduction in Obesity
Last checked: Nov 20, 2026Latest source record: Mar 8, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
671
Actual
Start
Dec 2009
Primary completion
Jul 2016
Study completion Oct 2016
Sponsor
- Lead sponsor
- Apollo Endosurgery, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 6, 2009
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A prospective, international, multi-center study of clinical outcomes and estimated healthcare resource expenditures associated with the treatment of obesity using the LAP-BAND AP® Adjustable Gastric Banding System.
Conditions
- Obesity
Interventions
LAP-BAND AP® Adjustable Gastric Banding SystemDevice
The LAP-BAND AP® is a device surgically implanted via a laparoscopic procedure. It is designed to induce weight loss in severely obese patients by limiting food consumption.
Primary outcomes
What the sponsor says the trial is designed to measure.
- %TBWLTime frame: 5 years
Locations
6 sites in 6 countries. Site status is shown where the registry gives one.
Site not named
Everett, Washington
Site not named
Adelaide, South Australia, Australia
Site not named
Jette, Belgium
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.